Table 3 Antibiotic susceptibility profiles of bacteria isolated
nadmission (%) | ndischarge(%) | Chi-2 | p-value | |
|---|---|---|---|---|
Cefoxitin (30 μg) | ||||
Susceptible | 44(77.19) | 14(26.42) | 29.49 | <0.0001 |
Intermediate | 2(3.51) | 2(3.77) | ||
Resistant | 11(19.30) | 37(69.81) | ||
Gentamicin (15 μg) | ||||
Susceptible | 52(91.23) | 46(86.79) | 0.56 | 0.4559 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 5(8.77) | 7(13.21) | ||
Erythromycin (15 μg) | ||||
Susceptible | 18(31.58) | 19(35.85) | 1.81 | 0.4051 |
Intermediate | 9(15.79) | 4(7.55) | ||
Resistant | 30(52.63) | 30(56.60) | ||
Clindamycin (2 μg) | ||||
Susceptible | 21(36.84) | 26(49.06) | 1.67 | 0.1957 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 36(63.16) | 27(50.94) | ||
Norfloxacin (5 μg) | ||||
Susceptible | 52(91.23) | 42(79.25) | 3.17 | 0.0749 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 5(8.77) | 11(20.75) | ||
Ciprofloxacin (5 μg) | ||||
Susceptible | 53(92.98) | 43(81.13) | 3.47 | 0.0624 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 4(7.02) | 10(18.87) | ||
Fusidic acid (10 μg) | ||||
Susceptible | 10(17.54) | 4(7.55) | 2.47 | 0.1160 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 47(82.46) | 49(92.45) | ||
Co-trimoxazole (1.25/23.75 μg) | ||||
Susceptible | 19(33.33) | 17(32.08) | 0.02 | 0.9878 |
Intermediate | 3(5.26) | 3(5.66) | ||
Resistant | 35(61.41) | 33(62.26) | ||
Penicillin G (10 μg) | ||||
Susceptible | 27(47.37) | 3(5.66) | 24.09 | <0.0001 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 30(52.63) | 50(94.34) | ||
Oxacillin (1 μg) | ||||
Susceptible | 43(75.44) | 16(30.19) | 22.61 | <0.0001 |
Intermediate | 0(0.00) | 0(0.00) | ||
Resistant | 14(24.56) | 37(69.81) | ||